GHDX
Genomic Health, Inc.
GHDX
GHDX
Delisted
GHDX was delisted on the 7th of November, 2019.
166 hedge funds and large institutions have $1.63B invested in Genomic Health, Inc. in 2018 Q2 according to their latest regulatory filings, with 42 funds opening new positions, 52 increasing their positions, 50 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
24% more funds holding
Funds holding: 134 → 166 (+32)
4% more repeat investments, than reductions
Existing positions increased: 52 | Existing positions reduced: 50
Holders
166
Holding in Top 10
4
Calls
$1.77M
Puts
$912K
Top Buyers
| 1 | +$40.4M | |
| 2 | +$11.2M | |
| 3 | +$10.7M | |
| 4 |
Goldman Sachs
New York
|
+$9.74M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$6.82M |
Top Sellers
| 1 | -$49.5M | |
| 2 | -$12.2M | |
| 3 | -$9.17M | |
| 4 |
American Century Companies
Kansas City,
Missouri
|
-$6.61M |
| 5 |
Charles Schwab
San Francisco,
California
|
-$4.89M |